Drugs Pharma

Canada recalls Unilever’s dry shampoo products over cancer concern

HQ Team October 21, 2022: Canada has recalled more than a million units of dry shampoo products of London-based Unilever after detecting a

Read More
Medical Pharma

Lupin buys inhalation brands from Sunovion for $75m

Lupin buys two inhalation brands for $75million

Read More
Drugs Medical

Cholera vaccine shortage forces one-dose strategy: WHO

Shortage of cholera vaccines forces global agencies to shift to single doses instead of recommended two

Read More
Drugs Medical

‘Universal’ Covid-19 treatment may be on the horizon

October 19, 2022: Researchers at Oregon State University have developed a proof of principle for a “universal” method of treating Covid-19. According to

Read More
Health Pharma

Physical inactivity may put 500 million people at risk of diseases: WHO

HQ Team October 19, 2022: In another eight years, about 500 million people globally will develop a spate of non-communicable diseases due to

Read More
Medical

Hetero buys J&J’s manufacturing site in India

HQ Team October 18, 2022: Hetero, an Indian pharmaceutical company, announced the acquisition of a brownfield manufacturing plant of Johnson & Johnson Private

Read More
Pharma

USFDA inspects Alembic’s pharma facility in Gujarat

HT Team October 18, 2022: The USFDA has inspected India’s Alembic Pharmaceuticals’ Oncology Injectable Formulation Facility at Panelav, Gujarat, according to a BSE

Read More
Drugs Pharma

Gavi, Moderna sign pact for Covid-19 vaccines

HQ Team October 18, 2022: Gavi, a public-private partnership Vaccine Alliance, has signed a new pact with Moderna to supply Covid-19 vaccines to low-income countries.

Read More
Health Medical

Prefer older people for liver transplant: Study

HT team October 17, 2022: If you are undergoing a liver transplant, will you choose a donor younger than you or older? The

Read More
Drugs Pharma

Biocon signs out-licencing pact with Yoshindo

HQ Team October 17, 2022: Biocon Biologics, a subsidiary of India’s Biocon, has inked an out-licencing pact with Japan’s Yoshindo Inc for selling

Read More